<table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th></th>
      <th>drug.brand_name</th>
      <th>company_name</th>
      <th>status</th>
      <th>drug_strength</th>
      <th>shortage_reason.en_reason</th>
      <th>shortage_reason.fr_reason</th>
      <th>en_discontinuation_comments</th>
      <th>fr_discontinuation_comments</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>0</th>
      <td>ACT AMPHETAMINE XR</td>
      <td>TEVA CANADA LIMITED</td>
      <td>active_confirmed</td>
      <td>25MG</td>
      <td>Demand increase for the drug.</td>
      <td>Augmentation de la demande pour le médicament</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <th>1</th>
      <td>ACT ENALAPRIL</td>
      <td>TEVA CANADA LIMITED</td>
      <td>active_confirmed</td>
      <td>8MG</td>
      <td>Demand increase for the drug.</td>
      <td>Augmentation de la demande pour le médicament</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <th>2</th>
      <td>ACT ENALAPRIL</td>
      <td>TEVA CANADA LIMITED</td>
      <td>active_confirmed</td>
      <td>4MG</td>
      <td>Demand increase for the drug.</td>
      <td>Augmentation de la demande pour le médicament</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <th>3</th>
      <td>ACT PIOGLITAZONE</td>
      <td>TEVA CANADA LIMITED</td>
      <td>active_confirmed</td>
      <td>15MG</td>
      <td>Demand increase for the drug.</td>
      <td>Augmentation de la demande pour le médicament</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <th>4</th>
      <td>ACT PIOGLITAZONE</td>
      <td>TEVA CANADA LIMITED</td>
      <td>active_confirmed</td>
      <td>30MG</td>
      <td>Demand increase for the drug.</td>
      <td>Augmentation de la demande pour le médicament</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <th>5</th>
      <td>ACT PRAMIPEXOLE</td>
      <td>TEVA CANADA LIMITED</td>
      <td>active_confirmed</td>
      <td>0.25MG</td>
      <td>Demand increase for the drug.</td>
      <td>Augmentation de la demande pour le médicament</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <th>6</th>
      <td>ACT PRAMIPEXOLE</td>
      <td>TEVA CANADA LIMITED</td>
      <td>active_confirmed</td>
      <td>0.5MG</td>
      <td>Demand increase for the drug.</td>
      <td>Augmentation de la demande pour le médicament</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <th>7</th>
      <td>ACT PRAMIPEXOLE</td>
      <td>TEVA CANADA LIMITED</td>
      <td>active_confirmed</td>
      <td>1.5MG</td>
      <td>Demand increase for the drug.</td>
      <td>Augmentation de la demande pour le médicament</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <th>12</th>
      <td>APO-QUININE</td>
      <td>APOTEX INC</td>
      <td>discontinued</td>
      <td>200MG</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <th>13</th>
      <td>APO-QUININE</td>
      <td>APOTEX INC</td>
      <td>discontinued</td>
      <td>300MG</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <th>14</th>
      <td>ERWINASE</td>
      <td>JAZZ PHARMACEUTICALS FRANCE SAS</td>
      <td>discontinued</td>
      <td>10000UNIT</td>
      <td>NaN</td>
      <td>NaN</td>
      <td>Distribution of Erwinase by Jazz Pharmaceuticals will end now that lot 205H121 (“CAMR205”) is exhausted. For all enquiries about future supply beyond Lot 205H121, please contact Sterimax Inc.: \r\nPhone: 1-800-881-3550\r\nFax: 1-877-546-7667\r\nEmail: customerservice@sterimaxinc.com\r\nWeb: www.sterimaxinc.com</td>
      <td>La distribution d'Erwinase par Jazz Pharmaceuticals est terminée depuis que le lot 205H121 ("CAMR205") est épuisé. Pour toute demande concernant la distribution au-delà du lot 205H121, veuillez contacter Sterimax Inc.: \r\nPhone: 1-800-881-3550\r\nFax: 1-877-546-7667\r\nEmail: customerservice@sterimaxinc.com\r\nWeb: www.sterimaxinc.com</td>
    </tr>
    <tr>
      <th>15</th>
      <td>HYZAAR</td>
      <td>MERCK CANADA INC</td>
      <td>active_confirmed</td>
      <td>50MG\r\n12.5MG</td>
      <td>Delay in shipping of the drug.</td>
      <td>Retard dans l’expédition du médicament</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <th>16</th>
      <td>LANTUS</td>
      <td>SANOFI-AVENTIS CANADA INC</td>
      <td>avoided_shortage</td>
      <td>100UNIT</td>
      <td>Other (Please describe in comments)</td>
      <td>Autre (Veuillez décrire dans les commentaires)</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
    <tr>
      <th>17</th>
      <td>SANDOZ D 10 000</td>
      <td>SANDOZ CANADA INCORPORATED</td>
      <td>active_confirmed</td>
      <td>10000UNIT</td>
      <td>Disruption of the manufacture of the drug.</td>
      <td>Perturbation de la fabrication du médicament</td>
      <td>NaN</td>
      <td>NaN</td>
    </tr>
  </tbody>
</table>